Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

NCT01175824 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Lispro Low Mixture (LM)
DRUG: Insulin Glargine
DRUG: Prandial Insulin Lispro

Sponsor

Eli Lilly and Company